ArticleEBioMedicine2017

MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.

Lingyu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.